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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYA period of mild brain overgrowth with an unknown etiology has been identified as one of the most common phenotypes in autism.
Here, we test the hypothesis that maternal inflammation during critical periods of embryonic development can cause brain overgrowth
and autism-associated behaviors as a result of alteredneural stemcell function. Pregnantmice treatedwith low-dose lipopolysaccharide at
embryonic day 9 had offspring with brain overgrowth, with a more pronounced effect in PTEN heterozygotes. Exposure to maternal
inflammation also enhanced NADPH oxidase (NOX)-PI3K pathway signaling, stimulated the hyperproliferation of neural stem and pro-
genitor cells, increased forebrainmicroglia, and produced abnormal autism-associated behaviors in affected pups. Our evidence supports
the idea that a prenatal neuroinflammatory dysregulation in neural stem cell redox signaling can act in concert with underlying genetic
susceptibilities to affect cellular responses to environmentally altered cellular levels of reactive oxygen species.INTRODUCTION
Macrocephaly, which is defined as having a head circum-
ference greater than the 97th percentile on normal growth
curves, can be caused by alterations in a number of genes,
including the tumor-suppressor genes PTEN and TSC.
Patients with these relatively rare mutations have a high
risk of autism spectrum disorders (ASD) (Fidler et al.,
2000; Klein et al., 2013; Zhou and Parada, 2012). The con-
ditional deletion of PTEN in mice produces brain over-
growth due in part to a sustained increase in neural stem
cell self-renewal and neurogenesis in the subventricular
zone (SVZ) (Groszer et al., 2006; Gregorian et al., 2009).
Both PTEN and TSC are negative regulators of the PI3K/
AKT/mTOR signaling pathway, which is a central regulator
of cellular growth and survival. In addition to overt macro-
cephaly, a more mild and pervasive brain overgrowth in
ASD was recently identified in retrospective studies of
head circumference (Courchesne et al., 2003; Schumann
et al., 2010). Although direct evidence of a relationship be-
tween brain overgrowth and the onset of ASD pathology
has yet to be demonstrated, induced brain overgrowth in
some animal models has been shown to result in abnormal
autism-associated behaviors (Fatemi et al., 2002; Bauman
et al., 2013).Stem Cell RIn addition to strong evidence for the genetic transmis-
sion of autism, studies have shown that certain perinatal
factors increase the risk for ASD and brain overgrowth
(Nordahl et al., 2013; Bill and Geschwind, 2009). These
environmental factors, through interactions with genetic
susceptibility during critical periods of development,
have the potential to play a significant role in the etiology
of ASD (Voineagu et al., 2011; Hallmayer et al., 2011). One
such environmental risk factor for ASD is the maternal
inflammatory response (MIR) (Patterson, 2011). Clinical
studies have identified a positive association between brain
overgrowth andmaternal inflammation, suggesting a path-
ogenic link between the immune system and brain growth
in ASD (Sacco et al., 2007; Nordahl et al., 2013). Although
the MIR has been linked to both autism and brain over-
growth, the mechanisms underlying its potential patho-
logical effects remain undefined.
Here, we propose a hypothesis that explains how a mild
MIR can contribute to brain overgrowth by enhancing
neural stem and progenitor cell proliferation through the
dysregulation of cellular redox signaling. This hypothesis
is based on evidence that reactive oxygen species (ROS)
at nontoxic levels can increase stem cell self-renewal and
neurogenesis through the reversible inactivation of PTEN
protein and subsequent enhancement of PI3K pathwayeports j Vol. 3 j 725–734 j November 11, 2014 j ª2014 The Authors 725
Figure 1. MIR Exposure Increases Brain Size Postnatally
(A) Mice body and brain weight and brain weight normalized to body weight of LPS-treated offspring at P0, P20, and P60 expressed as
percent of saline-treated control.
(B) Brain wet weight after vehicle or LPS treatment in PTEN heterozygous mice (n = 5) compared with their WT littermates (n = 8).
(C) Distribution of normalized brain weights in a single litter. The bottom and top of the boxplot represent the first and third quartiles of the
brainweightdistribution,with the secondquartile (themedian) indicatedby the band inside thebox andoutliers plottedas individual points.
(legend continued on next page)
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MIR-Induced Brain Overgrowthactivation (Le Belle et al., 2011). The MIR stimulates the
generation of ROS through the actions of various cytokines
and activation of the NADPH oxidase (NOX) enzyme,
which enhances signal transduction for many growth
and trophic factors that are important for normal brain
development (Beloosesky et al., 2012; Clement et al.,
2010; Chen et al., 2011). We hypothesize that the MIR ac-
tivates NOX, which in turn elevates cellular ROS levels and
leads to increased stem and progenitor proliferation during
early brain development, resulting in macrocephaly and
autism. This pathological process would be expected to
be enhanced by interaction with certain genetic suscepti-
bilities, such as heterozygous PTEN mutations.RESULTS
Exposure to Low-Dose Lipopolysaccharide-Induced
MIR Produces Brain Overgrowth in Most Offspring
Pregnant dams given a single injection with a low dose
of lipopolysaccharide (LPS) on embryonic day 9 (E9) gave
birth to pups with mild brain overgrowth (Figure 1A;
p < 0.05). Although at birth the pups had smaller body
weights, their brain sizes were not similarly smaller.
Because body and brain weight track together (e.g., see Re-
bello and Ramos, 2006), brain size is commonly normal-
ized to body weight (brain wet weight/body weight). Using
this normalization, we found that at birth and at postnatal
day 20 (P20) there was an approximate 15% increase in
brain weight in mice exposed to MIR (P20; Figure 1A; p <
0.05). However, by P60 the overgrowth was no longer sig-
nificant. On the other hand, if one considers the gross
brain wet weight alone, the brains of MIR-exposed pups
were not larger at birth, but became larger than those of
controls by P20. Exposure to low-level MIR resulted in a
slightly larger litter size, which led us to repeat key experi-
ments after normalizing the litter size at birth through
cross-fostering, which did not alter any of the outcome
measures (Figure S1A available online). We also tested the
effects of embryonic MIR exposure on postnatal brain
weight in PTEN heterozygous (Het) and wild-type (WT)
littermate mice. We found that Het pups from LPS-treated
dams had 34%–58% greater brain weights than their WT
littermates at birth, whereas Het brains were only approxi-
mately 8% larger than WT brains from vehicle-treated
dams. This demonstrates a dramatic effect from the interac-
tion of a genetic susceptibility with an environmental fac-
tor such as the MIR (Figure 1B; p < 0.01).(D) Percentage of pups with brain wet weights or normalized brain w
(E) Percentage of mice that displayed megalencephaly (2 SD greate
from n = 3 litters of 10–18 pups each. All data are presented as
controls.
Stem Cell RAlthough as a group theMIR-exposed offspring displayed
an average increase in brain size as compared with controls,
not all of the pups in a litter experienced brain overgrowth.
There was a wide distribution of brain wet weights in MIR-
exposed litters. At birth, no pups from the LPS treatment
group had a brain wet weight higher than the highest brain
wet weight in the control pups (Figure 1C). However, by
P20, about 30% of the pups had brain weights greater
than the highest brain weight in the control group, and
when brain size was normalized to body weight, approxi-
mately 45% of MIR-exposed pups had larger brains than
the largest controls (Figure 1D). Furthermore, up to 25%
of MIR-exposed mice displayed megalencephaly (2 SD
above the mean for typically developing age-matched con-
trols; Figure 1E). Therefore, the overgrowth we observed
was clearly evolving postnatally, but did not universally
affect all offspring. No sex differences were observed in
LPS-induced brain overgrowth (Figure S1B).Early Embryonic MIR Exposure Expands Cortical Size
and Has Long-Term Stimulatory Effects on Forebrain
Microglia and Proliferation in the Neurogenic SVZ
Niche of Offspring
We observed an increased cortical thickness and cortical
area, but no change in corpus callosum thickness in the
pups from the LPS treatment group comparedwith controls
(Figure 2A; p < 0.05). Embryonic LPS treatment resulted in a
significant increase in IBA1+ microglia throughout the
brain, with only raremicroglia locatedwithin the SVZ itself.
The increase in microglia was greater at E18 but remained
significantly elevated at birth (Figures 2B and S2A; p <
0.05). It remains to be determined whether this increase
in microglia plays a role in stimulating progenitor prolifer-
ation (Antony et al., 2011) or in the phagocytotic pruning
of cells produced in excess following MIR exposure (Cun-
ningham et al., 2013).
Our mild LPS treatment at E9 also induced a significant
increase in postnatal SVZ proliferation (Figure 2C; p <
0.05) that corresponded to an increase in proliferative Nes-
tin progenitor cells (Figures 2D, S2B, and S2C) that were
also MASH1 positive (Figures 2E and S2D), indicating that
a neural progenitor population underlies this MIR effect.
To further clarify whether the enhanced SVZ cell division
also indicated an increase in neural stem cell self-renewal,
we performed a clonal density neurosphere-forming assay.
Acutely dissociated SVZ cells from the MIR-exposed
pups displayed significantly enhanced self-renewal (clonaleights larger than the largest control brain.
r than the mean control brain size). Unless specified, all data are
mean ± SEM. The red bars represent the normalized SEM of the
eports j Vol. 3 j 725–734 j November 11, 2014 j ª2014 The Authors 727
Figure 2. Cortical Size and SVZ Stem and Progenitor Cell Proliferation Are Increased following LPS Treatment
(A) Cortex thickness and area and corpus callosum thickness in tissue sections from P0 pup brains.
(B) Number of IBA1+ microglia in the forebrain of MIR-exposed and control offspring on E18 and P0.
(C) Stereological counts of BrdU+ cells as a percentage of total cells in the SVZ at P0 (n = 4 animals per group).
(D) Fluorescence-activated cell sorting (FACS) quantification of acutely dissociated P0 SVZ stained for Ki67 and Nestin.
(legend continued on next page)
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MIR-Induced Brain Overgrowthsphere number) and increased proliferation (sphere diame-
ters), and they were similarly multipotent, producing neu-
rons, astrocytes, and oligodendrocytes (Figure 2F; p < 0.05).
These effects were also not gender specific (Figure S2E).
Subsequent serial clonal passages after the primary clonal
culture did not maintain this increased self-renewal (data
not shown), indicating that the cells were likely stimulated
by their in vivo environment—an effect that was not sus-
tained during long-term culture in the same high-growth
factor environment in vitro. Early postnatal, cortical-deri-
ved progenitor cells typically have a limited self-renewal
and neurogenic capacity (Seaberg et al., 2005). However,
we found that cortical progenitors derived from MIR-
exposed pups at birth had a significantly prolonged self-
renewal capacity compared with vehicle-treated pups,
suggesting the possibility that ectopic stem cells were pre-
sent in the cortex or that there was delayed maturation of
cells after MIR (Figure 2G; p < 0.05).
MIR Exposure Is Associated with Abnormal Behaviors
in Offspring
We examined the MIR-exposed mice for several autism-
associated behaviors. Neonatal (P7) pups from the LPS
treatment group displayed a deficit in ultrasonic vocaliza-
tions when separated from their dam (Figure 3A; p <
0.05). In a three-chamber social interaction test, the MIR-
exposed mice showed lower levels of interaction with the
mouse in the social chamber and more time sniffing an
empty cup compared with controls. MIR-exposed mice
also preferred to spend most of their time in the chamber
with the empty cup and less time in the chamber with
the mouse (Figure 3B; p < 0.01). Additionally, unlike con-
trols, MIR-exposed offspring showed less preference for
social novelty, spending less time interacting with a new,
unknown mouse (Figure S3; p < 0.01). Similarly, the
elevated plus maze indicated that MIR mice had a higher
level of anxiety due to a decrease in the amount of time
spent in the open arms of the maze and an increase in
the latency to enter the open arms during the testing period
(Figure 3C; p < 0.05). At P60 the MIR-exposed mice dis-
played excessive repetitive grooming behavior, which was
highly correlated with brain size (Figure 3D; p < 0.01, r =
0.918). Behavioral deficits were not gender dependent
(data not shown). Finally, the MIR mice showed normal
postnatal weight gain (Figure 3E) and normal mobility dur-
ing behavioral testing (Figure 3F), demonstrating that their
behavioral deficits were not due to gross motor problems.(E) Stereological counts of BrdU+/MASH1+ cells in the SVZ (n = 4 pe
(F) Sphere formation and diameter, and multipotency of clonal cultu
(G) Numbers of clonal neurospheres from postnatal cortex in control a
data are from n = 3 litters of 10–18 pups each; *p < 0.05. All data are p
of the controls.
Stem Cell RMIR Induces Dysregulation of the Redox Balance
in the SVZ
Endogenous cellular ROS levels were elevated in the post-
natal SVZ of MIR-exposed pups in both males and females
(Figure 4A). In vivo inhibition of the ROS-generating
enzyme NOX following LPS treatment reduced brain over-
growth in WT and PTEN heterozygous offspring but pro-
duced brain undergrowth in some pups (Figures 4B and
S4A; p < 0.01). Inhibition of NOX from the time of LPS in-
jection on E9 until birth also prevented the increase in fore-
brainmicroglia (Figures 4C and S4B; p < 0.01) and SVZ stem
cell self-renewal (Figure 4D; p < 0.01). We observed an in-
crease in AKT and pS6 activation in acutely dissected SVZ
fromMIR-exposed pups, which could be rescued by prena-
tal inhibition of NOX with apocynin (Figures 4E and S4C).
Finally, we tested the ability of NOX inhibition to rescue
the two most significantly abnormal behaviors caused by
MIR exposure: vocalization and grooming. We found that
it could rescue the excessive grooming behavior at P20,
but not the early vocalization deficit (Figures 4F and 4G;
p < 0.05). It is possible the daily, prenatal apocynin treat-
ment paradigm we utilized was overly aggressive, resulting
in smaller brains in somemice at birth. If mild brain under-
growth also affects early vocalization behavior, this could
explain why we failed to see rescue of abnormal behavior
until older ages, at which time brain size was normalized
in treated offspring. This highlights the difficulty of devel-
oping effective therapeutic interventions that aim to
restore a normal redox balance in the developing brain,
since both too much and too little cellular ROS can have
deleterious effects (Le Belle et al., 2011).DISCUSSION
The fact that mild brain overgrowth is the most common
endophenotype in ASD suggests that the mechanism un-
derlying this pervasive accelerated growth could result
from the convergence of different genetic susceptibilities
in combination with environmental stimulation onto
common pathways. It is our theory that a large subset of in-
dividuals with autism and mild brain overgrowth has the
final common pathway of enhanced ROS-signaling with
resultant PI3K/AKT pathway stimulation, even though
different genetic mutations and immune-activating envi-
ronmental factors may contribute to this activation. The
types of genetic mutations that could impact the cellularr group).
res from acutely dissociated P0 SVZ.
nd MIR-exposed offspring at various passages. Unless specified, all
resented as mean ± SEM. The red bars represent the normalized SEM
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Figure 3. MIR-Exposed Mice Display Autism-Associated Deficits in Behaviors
(A) Mean duration of ultrasonic vocalizations by P7 pups when separated from the dam.
(B) Mean percent total time spent in each condition in the three-chamber social interaction test.
(C) Mean percent total time spent in each maze location and the latency to enter open arms in the elevated plus maze test.
(D) Correlation between brain size and repetitive grooming behavior. Data shown were obtained from each pup from two litters.
(E) Average weight gain in control and treated animals over 14 postnatal days.
(F) Average total path length traveled during the three-chamber social interaction test. n = 16 mice per group; *p < 0.05. All data are
presented as mean ± SEM.
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MIR-Induced Brain Overgrowthredox balance in response to MIR include alterations
in antioxidant genes, immune-response genes, and ROS-
generating genes (e.g., NADPH oxidase), or in genes encod-
ing proteins that can be inactivated and regulated by ROS,
such as PTEN. Many of these mutations have already been
identified in ASD populations (Luo et al., 2012; Klein et al.,
2013; Rose et al., 2012; Voineagu et al., 2011).
Clearly, not everymaternal immune-activating event dur-
ing early pregnancy results in the development of autism,
raising the question as to what influences the deleterious
fetal response to MIR in those infants who do develop
autism. In our MIR model, we found that not all pups in a
litter experienced brain overgrowth and this was not related
to gender, consistentwithwhat others have found regarding
autoimmune-related brain overgrowth in both children
(Nordahl et al., 2013) and primates (Bauman et al., 2013).
Furthermore, although we found that rescue of MIR-
induced brain overgrowth and pathway activation was
possible with prenatal NOX inhibition, it also had the nega-
tive effect of causing brainundergrowth in somepups. Thus,
there is a heterogeneous response to an altered redox
balance during brain development among offspring, sug-
gesting that the effects of this dysregulation may depend
on underlying individual susceptibilities. Here, we exam-
ined a specific genetic susceptibility, PTEN. Mutations in
PTEN affect only 1 in 242,063 individuals in the general
population, but are found in approximately 4%of ASD indi-
viduals (Hobert et al., 2013; Varga et al., 2009). As a proof of
principle, we have shown that PTEN heterozygosity inter-
acts with MIR to produce even greater brain overgrowth
than can be induced in WT mice. This is in agreement
with previous evidence that heterozygous PTEN deletion in-
teracts with ROS stimulation by enhancing stem cell prolif-
eration evenmore than can be achieved inWTcells (Le Belle
et al., 2011). Similarly, TSC haploinsufficiency has been
shown to interact with MIR to cause autism-related behav-
iors inpups (Ehninger et al., 2012). AlthoughourMIRmodel
most closely replicates key phenotypes associated with
autism, there is a considerable overlap of some genetic and
environmental risk factors, brain pathology, and behavioral
abnormalities with other neurodevelopmental disorders,
such as schizophrenia (Fatemi et al., 2002). Consequently,
MIR-mediated brain overgrowth and the underlying cellular
and signaling mechanisms that we have identified could
represent a final commonpathway for the abnormal pheno-
types shared by several neuropsychiatric disorders.
Many cellular mechanisms have the potential to con-
tribute to enlarged brain size and to faulty connections
among centers in the brain that are thought to be linked
to abnormal behaviors in ASD. While neurite outgrowth
and pruning normally occur during the time period in
which the accelerated brain growth is observed in humans,
they are not the only candidates capable of contributing toStem Cell Rthis phenomenon. We hypothesize that increased cortical
cell numbers resulting from enhanced SVZ proliferation
and, possibly, the greater self-renewal capacity of cortical
progenitors could have a cascade effect on later down-
stream processes in development through a direct increase
in neuronal numbers, as has been reported in autism
(Courchesne et al., 2011), or indirectly through altered glial
cell numbers (Herbert, 2005). These processes could then
trigger abnormalities in connectivity resulting from altered
lamination, neurite outgrowth (Courchesne et al., 2011;
Stoner et al., 2014), or other processes. Our findings indi-
cate that environmental factors such as mild maternal
inflammation and subsequent alterations in the neural
stem cell redox balance can significantly alter brain devel-
opment in affected offspring and could set up a cascade
of cellular changes that lead to brain overgrowth and
abnormal behaviors in autism.EXPERIMENTAL PROCEDURES
Animals
Unless otherwise specified, all experiments were carried out on
time-mated CD1 mice from Charles River Laboratories. Female
PTEN floxed mice were crossed with hemizygous Nestin-Cre male
mice (The Jackson Laboratory), generating pregnant dams carrying
both PTEN heterozygous and WT offspring. MIR was induced
with low-dose LPS (E. coli serotype 0111:B4; 0.008 mg/kg, Sigma)
administered in a single I.P. injection on E9 of gestation. In vivo
administration of apocynin (5 mg/kg/day, I.P.; Sigma) was per-
formed daily from E9 until birth. Bromodeoxyuridine (BrdU;
50 mg/kg/injection) was injected subcutaneously at birth and
pups were perfused 4 hr later. Replicates of three pregnant dams
with 10–18 pups per litter were used in all experiments unless spec-
ified otherwise.
Immunohistochemistry
Brain sections were immunostained with BrdU (Exalpha), IBA1
(AbCam), Nestin (BD Biosciences), or MASH1 (BD Biosciences)
antibodies with the appropriate Alexa fluorescent secondary anti-
bodies, and positive cells were quantified using the unbiased opti-
cal fractionator approach (StereoInvestigator; MicroBrightField).
Hoescht counterstain was used to measure cortical thickness and
area, as well as corpus callosum thickness, using image analysis
software (MCID; Imaging Research).
Behavioral Testing
Ultrasonic vocalization, three-chamber social interaction, and
elevated plus maze tests were performed on adult mice according
to the methods of Crawley (2007). A repetitive grooming test was
performed according to themethods of Pen˜agarikano et al. (2011).
Statistical Analysis
All data are expressed as mean ± SEM unless otherwise indicated;
t tests were performed using Microsoft Excel to determine the sta-
tistical significance of treatment sets. For multiple comparisons,eports j Vol. 3 j 725–734 j November 11, 2014 j ª2014 The Authors 731
Figure 4. MIR-Exposed Pups Have Dysregulated SVZ ROS Levels, which Contributes to Brain Overgrowth
(A) Endogenous ROS levels in SVZ cells measured by DCFDA dye on P3 (results are pooled samples of three or four mice per group).
(B) Brain weights (corrected for body weight) of MIR-exposed pups with and without NOX inhibition (APO) expressed as a percentage of
vehicle controls.
(C) IBA1+microglia present at birth in the forebrain of MIR-exposed pups with and without NOX inhibition, determined by FACS acquisition
and expressed as a percentage of vehicle controls.
(D) Mean number of clonal neurospheres from the SVZ of MIR-exposed pups as a percentage of vehicle control at each passage indicated.
(legend continued on next page)
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MIR-Induced Brain Overgrowthone- or two-way ANOVA was performed as appropriate, and Bon-
ferroni post hoc t tests were done to determine significance. The
Spearman rank order test was used for correlation analysis. Alpha
values were 0.05 except when adjusted by the post hoc tests.
For more information, please refer to Supplemental Experi-
mental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2014.09.004.ACKNOWLEDGMENTS
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